Testing effectiveness (Phase 2)WithdrawnNCT04901299
What this trial is testing
Fulvestrant + Neratinib In Breast Cancer
Who this might be right for
Stage IV (Metastatic) Breast CancerMetastatic Breast CancerER Positive Breast Cancer+3 more
Massachusetts General Hospital